Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Papp

Showing results (351-360 of 393) with videos related to

Pageof 40
Sort By:
Mbio|July 4, 2019
Population Structure, Molecular Epidemiology, and β-Lactamase Diversity among Stenotrophomonas maltophilia Isolates in the United StatesMaria F Mojica, Joseph D Rutter, Magdalena Taracila, et al.
Antimicrobial Agents and Chemotherapy|April 4, 2018
Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing EnterobacteriaceaeKrisztina M Papp-Wallace, Melissa D Barnes, Jim Alsop, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2025
Structure and mechanism of taniborbactam inhibition of the cefepime-hydrolyzing, partial R2-loop deletion <i>Pseudomonas</i>-derived cephalosporinase variant PDC-88Andrew R Mack, Vijay Kumar, Christopher R Bethel, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2020
<i>In Vitro</i> Antibacterial Activity and <i>In Vivo</i> Efficacy of Sulbactam-Durlobactam against Pathogenic <i>Burkholderia</i> SpeciesKrisztina M Papp-Wallace, Adam B Shapiro, Scott A Becka, et al.
FEBS Letters|September 13, 2025
Mechanistic basis for inhibition of the extended-spectrum β-lactamase GES-1 by enmetazobactam and tazobactamMichael Beer, Philip Hinchliffe, Marko Hanževački, et al.
Antimicrobial Agents and Chemotherapy|August 9, 2017
Avibactam Restores the Susceptibility of Clinical Isolates of Stenotrophomonas maltophilia to AztreonamMaria F Mojica, Krisztina M Papp-Wallace, Magdalena A Taracila, et al.
Diagnostic Microbiology and Infectious Disease|July 10, 2018
Sequence heterogeneity of the PenA carbapenemase in clinical isolates of Burkholderia multivoransScott A Becka, Elise T Zeiser, Steven H Marshall, et al.
Pathogens (Basel, Switzerland)|April 30, 2021
Human Pleural Fluid and Human Serum Albumin Modulate the Behavior of a Hypervirulent and Multidrug-Resistant (MDR) <i>Acinetobacter baumannii</i> Representative StrainCamila Pimentel, Casin Le, Marisel R Tuttobene, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2019
Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPCMelissa D Barnes, Magdalena A Taracila, Caryn E Good, et al.
Mbio|February 17, 2021
Structural Characterization of Diazabicyclooctane β-Lactam "Enhancers" in Complex with Penicillin-Binding Proteins PBP2 and PBP3 of Pseudomonas aeruginosaMalligarjunan Rajavel, Vijay Kumar, Ha Nguyen, et al.
Pageof 40

Showing results (351-360 of 393) with videos related to

Sort By:
Pageof 40
Mbio|July 4, 2019
Population Structure, Molecular Epidemiology, and β-Lactamase Diversity among Stenotrophomonas maltophilia Isolates in the United StatesMaria F Mojica, Joseph D Rutter, Magdalena Taracila, et al.
Antimicrobial Agents and Chemotherapy|April 4, 2018
Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing EnterobacteriaceaeKrisztina M Papp-Wallace, Melissa D Barnes, Jim Alsop, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2025
Structure and mechanism of taniborbactam inhibition of the cefepime-hydrolyzing, partial R2-loop deletion <i>Pseudomonas</i>-derived cephalosporinase variant PDC-88Andrew R Mack, Vijay Kumar, Christopher R Bethel, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2020
<i>In Vitro</i> Antibacterial Activity and <i>In Vivo</i> Efficacy of Sulbactam-Durlobactam against Pathogenic <i>Burkholderia</i> SpeciesKrisztina M Papp-Wallace, Adam B Shapiro, Scott A Becka, et al.
FEBS Letters|September 13, 2025
Mechanistic basis for inhibition of the extended-spectrum β-lactamase GES-1 by enmetazobactam and tazobactamMichael Beer, Philip Hinchliffe, Marko Hanževački, et al.
Antimicrobial Agents and Chemotherapy|August 9, 2017
Avibactam Restores the Susceptibility of Clinical Isolates of Stenotrophomonas maltophilia to AztreonamMaria F Mojica, Krisztina M Papp-Wallace, Magdalena A Taracila, et al.
Diagnostic Microbiology and Infectious Disease|July 10, 2018
Sequence heterogeneity of the PenA carbapenemase in clinical isolates of Burkholderia multivoransScott A Becka, Elise T Zeiser, Steven H Marshall, et al.
Pathogens (Basel, Switzerland)|April 30, 2021
Human Pleural Fluid and Human Serum Albumin Modulate the Behavior of a Hypervirulent and Multidrug-Resistant (MDR) <i>Acinetobacter baumannii</i> Representative StrainCamila Pimentel, Casin Le, Marisel R Tuttobene, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2019
Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPCMelissa D Barnes, Magdalena A Taracila, Caryn E Good, et al.
Mbio|February 17, 2021
Structural Characterization of Diazabicyclooctane β-Lactam "Enhancers" in Complex with Penicillin-Binding Proteins PBP2 and PBP3 of Pseudomonas aeruginosaMalligarjunan Rajavel, Vijay Kumar, Ha Nguyen, et al.
Pageof 40